Rekha Jhunjhunwala-backed Inventurus Knowledge Solutions Ltd is set to get listed on BSE and NSE today following a highly subscribed IPO, with experts advising potential profit booking amid expectations of strong listing gains. The healthcare technology company’s Rs 2,498-crore public issue was subscribed nearly 53 times during the three-day bidding, led by robust demand from qualified institutional buyers (QIBs), who bid 81 times their allotted portion.
Expert views on Inventurus listing, and investor strategy
Prashanth Tapse, Sr VP Research at Mehta Equities, said that investors who have been allotted Inventurus shares may consider booking profits if the stock lists with gains exceeding 25 percent.
“While the IPO consisted entirely of an OFS and was fully priced, the strong demand from QIBs and a unique business model should help the company sustain a premium valuation post-listing. Long-term investors may consider holding despite potential short-term volatility,” he said.
Also read | Bitcoin tumbles most in over three months on Jerome Powell's comment on the digital currency
Sagar Shetty, Research Analyst at StoxBox, said that the company’s scalable platform and automation-led approach to optimise clinical and financial processes help enhance profitability. He advised investors to stay invested from a medium to long-term perspective, citing growth potential driven by the widening supply-demand gap in the healthcare sector and increasing healthcare spending.
Inventurus IPO: Strong subscription across categories
The IPO saw a strong response across investor categories. Non-institutional investors subscribed over 23 times their reserved quota, while retail investors’ portion was subscribed about 15 times. The employee portion also received healthy participation with a 5 times subscription, according to data from the stock exchanges.
The entire IPO consisted of an offer for sale (OFS) of 1.88 crore shares, meaning the company itself will not receive any proceeds. The funds raised, net of issue-related expenses, will go to the selling shareholders, including Rekha Jhunjhunwala.
Also read | DAM Capital Advisors mops up over Rs 251 crore via anchor book, Rs 840-crore IPO to open on December 19
Inventurus Knowledge Solutions, incorporated in 2006, specialises in providing administrative and support services to healthcare enterprises, helping streamline processes for healthcare providers in the US, Canada, and Australia.
Inventurus shares GMP, experts recommendation
The stock is reportedly trading at a grey market premium (GMP) of around 30 percent ahead of its listing, indicating positive sentiment among investors. Analysts expect the company’s focus on technology-driven solutions and its comprehensive service offerings to command a premium valuation in the market.
Experts suggest different strategies depending on investment goals. Conservative investors can consider booking profits if significant listing gains materialise, while long-term investors may benefit from holding the stock to capitalise on the company’s growth opportunities in the healthcare sector. Non-allotted investors may also look for opportunities to accumulate shares if post-listing profit booking leads to a dip in the stock price.
Disclaimer: The views and investment tips expressed by experts on Moneycontrol are their own and not those of the website or its management. Moneycontrol advises users to check with certified experts before taking any investment decisions.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
